Adamis: 2Q Earnings Snapshot

August 10, 2018

SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Friday reported a loss of $9.7 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 29 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The biopharmaceutical company posted revenue of $3.9 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $4.1 million.

The company’s shares closed at $3.25. A year ago, they were trading at $4.55.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMP at https://www.zacks.com/ap/ADMP

Update hourly